Identification of new common predictive biomarkers to stratify TNBC breast cancer patients for treatment with emerging immune checkpoints

Project Details

AcronymINCOM (RCMS-2020)
StatusFinished
Effective start/end date15/10/201/01/22

Funding

  • Fondation de Recherche sur le Cancer et les Maladies du Sang, Luxembourg: €55,626.00